Join
Live feed
·
PRReleasevia Quantisnow
Tevogen Bio Holdings Inc. logo

Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery

ByQuantisnow·Wall Street's wire, on your screen.
TVGN· Tevogen Bio Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVGN (Tevogen Bio Holdings Inc.) and more on Quantisnow.